mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.003 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.003 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.003 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.003 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |